Patent details

Basic Information

Publication number:

EP1381356

PCT Application Number:

PCT/US/2002/010773

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP027639624

PCT Publication Number:

WO/2002/080897

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

USE OF (Z)-2-CYANO-3-HYDROXY-BUT-2-ENOIC ACID-(4'-TRIFLUOROMETHYLPHENYL)-AMIDE FOR TREATING MULTIPLE SCLEROSIS

French Title of Invention:

UTILISATION DE L'ACIDE (Z)-2-CYANO-3-HYDROXY-BUT-2-ENOIQUE-(4'-TRIFLUOROMETHYLPHENYL)-AMIDE POUR LE TRAITEMENT DE LA SCLEROSE EN PLAQUES

German Title of Invention:

VERWENDUNG VON (Z)-2-CYANO-3-HYDROXY-BUT-2-ENSÄURE-(4'-TRIFLUOROMETHYLPHENYL)-AMID ZUR BEHANDLUNG DER MULTIPLEN SKLEROSE

SPC Number:

92366

Dates

Filing date:

04/04/2002

Grant date:

28/05/2008

EP Publication Date:

28/05/2008

PCT Publication Date:

17/10/2002

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

21/01/2004

EP B1 Publication Date:

28/05/2008

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

04/04/2022

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

07/05/2019

 

 

Name:

Sanofi-Aventis Deutschland GmbH

Address:

Brüningstrasse 50, 65929 Frankfurt am Main, Germany (DE)

History of Owners

From:

20/07/2016

To:

07/05/2019

Name:

AVENTISUB LLC

Address:

3711 KENNETT PIKE, SUITE 200, GREENVILLE, DELAWARE 19807, United States (US)

From:

04/04/2002

To:

19/07/2016

Name:

Aventis Pharmaceuticals Inc.

Address:

55 Corporate Drive, Bridgewater, NJ 08807, United States (US)

Agent

Name:

VAN MALDEREN MICHEL

From:

28/08/2008

Address:

ROUTE D'ARLON 261, 8002, STRASSSEN, Luxembourg (LU)

To:

Inventor

Name:

WETTSTEIN Joseph

Address:

United States (US)

Priority

1

Priority Number:

281685 P

Priority Date:

05/04/2001

Priority Country:

United States (US)

2

Priority Number:

0123571

Priority Date:

02/10/2001

Priority Country:

United Kingdom (GB)

Classification

Main IPC Class:

A61K 31/165;

Publication

Bulletin

Bulletin Heading:

CO

Bulletin edition number:

2019/07

Publication date:

11/06/2019

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20190000184A

Date Registered:

07/05/2019

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

MARKS & CLERK (Luxembourg) LLP

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

Sanofi-Aventis Deutschland GmbH

Address:

Brüningstrasse 50, 65929 Frankfurt am Main, Germany (DE)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

24/03/2021

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
07/05/2019	Outgoing Correspondence	1
07/05/2019	Request For Change	5